Atlas Trials

S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia

Clinical trial NCT00049179 · COMPLETED

Trial details

NCT number
NCT00049179
Sponsor
SWOG Cancer Research Network
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Leukemia
Start date
2003-04-01
Primary completion
2005-12-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.